Announcements
- Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
- Galapagos toont innovatieve aanpak in hematologische kankerzorg met presentaties over klinische en translationele data op EBMT congres 2024
- Galapagos publiceert 2023 jaarverslag en kondigt jaarlijkse Gewone Algemene en Buitengewone Algemene Aandeelhoudersvergaderingen aan
- Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
- Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur
- Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
- Galapagos kondigt 2023 jaarresultaten en vooruitzichten 2024 aan
- Galapagos announces full year 2023 results and outlook for 2024
- Galapagos presents at EBMT-EHA annual meeting 2024
- Galapagos presenteert op de jaarlijkse EBMT-EHA meeting van 2024
More ▼
Key statistics
As of last trade Galapagos NV (GXEA:BER) traded at 26.00, 0.78% above its 52-week low of 25.80, set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.00 |
---|---|
High | 26.00 |
Low | 26.00 |
Bid | 26.40 |
Offer | 29.00 |
Previous close | 26.20 |
Average volume | 0.00 |
---|---|
Shares outstanding | 65.90m |
Free float | 49.18m |
P/E (TTM) | -- |
Market cap | 1.92bn USD |
EPS (TTM) | -0.0645 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 07:05 BST.
More ▼